Detalhe da pesquisa
1.
Early Treatment with Pegylated Interferon Lambda for Covid-19.
N Engl J Med
; 388(6): 518-528, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780676
2.
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Hepatology
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506926
3.
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Hepatology
; 79(1): 39-48, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399238
4.
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
Hepatology
; 79(6): 1279-1292, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146932
5.
Characterizing the burden of biliary tract cancers across 28 hospitals in Ontario, Canada.
Cancer
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361443
6.
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
J Hepatol
; 80(2): 243-250, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898348
7.
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
J Hepatol
; 80(5): 730-743, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199298
8.
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
J Hepatol
; 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527524
9.
Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss and Mortality in Recurrent Primary Biliary Cholangitis after Liver Transplantation.
J Hepatol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821360
10.
Comparing Time to Diagnosis and Treatment Between Younger and Older Adults With Colorectal Cancer: A Population-Based Study.
Gastroenterology
; 164(7): 1152-1164, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841489
11.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
12.
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
J Viral Hepat
; 31(4): 197-207, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243144
13.
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.
Hepatology
; 78(6): 1698-1710, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37278241
14.
Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario.
J Obstet Gynaecol Can
; 46(6): 102423, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452927
15.
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
Clin Infect Dis
; 77(Suppl 3): S262-S269, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579209
16.
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(12): 3089-3096.e1, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004973
17.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
18.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
19.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Gastroenterology
; 163(6): 1630-1642.e3, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150526
20.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174